Submissions

SCOPE

• High Ranking: The journal is ranked #1 among Russian publications and is positioned in Q3 in three SCImago Journal Rank (SJR) categories: Psychiatry and Mental Health; Public Health, Environmental and Occupational Health; and Clinical Psychology.
• Citation Growth:The journal demonstrates stable growth in citations, with a current Scopus CiteScore Tracker of 2.7 (January 2026). Its two-year RSCI Impact Factor is 1.634 (2024). Notably, 70% of the journal's citations come from international and Russian journals indexed in Web of Science (WoS) and Scopus.
• Active Readership: Articles published in the journal have garnered over 1.5 million views and downloads. More than 1,700 subscribers follow new publications across Russian and international social media channels.
• Media Coverage: Research published in the journal is regularly featured in leading media outlets, accumulating over 150 media mentions in 2024–2025.
• International Collaboration: The journal's Editorial Board comprises 29 leading experts from 12 countries. Authors from 35 countries have published in the journal, accounting for approximately 30% of all publications.

COMPREHENSIVE AUTHOR SUPPORT

• Editorial Platform: A streamlined online system for manuscript submission and tracking.
• Multi-Level Quality Assessment: Manuscripts undergo rigorous peer review, scientific editing, and copyediting to ensure high scientific quality and value.
• Methodological Guidance: Detailed author guidelines assist in preparing manuscripts and accurately describing research findings.
• Professional Translation: Accepted manuscripts are translated into either Russian or English with scientific precision. This makes research by Russian authors accessible to a global audience and work by international colleagues available to Russian-speaking readers.
• Proofreading.
• Illustration Design: We create and refine graphs, charts, and diagrams to ensure clear and compelling data visualization.
• Open Access: All articles are published open access under a Creative Commons license, ensuring free and unrestricted dissemination.
• Promotion & Visibility: We write and distribute press releases, produce video abstracts, podcasts, and expert interviews with authors, and actively promote articles on social media.
• Real-Time Metrics: Authors receive real-time statistics on article views, downloads, and citations.
• PubMed Central (PMC): All published scientific articles are deposited in PubMed Central (PMC), the premier electronic archive for biomedical literature, significantly increasing their global visibility and citation potential.

TRANSPARENT EDITORIAL PROCESS

• Stringent Scientific Selection: The editorial board accepts only 19% of submitted manuscripts, ensuring the publication of only the most significant research.
• Transparent Process:The entire editorial workflow — from submission to publication — is managed online. All participants (authors, reviewers, editors) can track the manuscript's status and their tasks in real time. The editorial office maintains constant communication and keeps authors informed. Each manuscript typically undergoes no more than 3 rounds of review by the scientific editor and reviewers. Watch our video about the editorial process.
• Fast Publication Timelines:
  • A decision on initial suitability is made within an average of 5 days of submission.
  • Following final acceptance, articles are published Online First within 21 days.
• Online First Publication: Accepted articles are published on the journal's website in the "Accepted Articles" section with a DOI assigned immediately. From the day of Online First publication, the article is fully accessible and citable.

• Journal's scope: psychiatry, clinical psychology, psychotherapy, public health and healthcare organization, epidemiology of mental disorders, fundamental research in neuropsychology and psychiatry, and related interdisciplinary studies.

• Article type: Original research, review, clinical case, study protocol, opinion, etc. (see specific requirements for each article type).

• Language: Is written in English.

• Scientific novelty and relevance, with conclusions that are meaningful to mental health professionals.

• Clear, scientific language that is accessible to specialists in adjacent fields.

• Is original: Is not under consideration by any other publication and has not been published previously.

• Formatting: The journal follows the "Your Paper Your Way" principle and does not enforce strict initial text formatting requirements.

When preparing a manuscript for submission, authors should adhere to guidelines based on the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations), developed by the International Committee of Medical Journal Editors.

All the required supporting documents will be submitted together with the manuscript. Authors are required to upload a scanned original of the completed cover letter in PDF format. The cover letter should be signed by all the authors. In a cover letter the authors should confirm that:

• all participants who have made a significant contribution to the study are presented as co-authors;
• those who did not participate in the study should not be listed as co-authors;
• all co-authors have seen and approved the final version of the document and agreed to submit it for publication.

When submitting the manuscript to the journal, please consider the Uniform Requirements for Manuscripts Submitted to Biomedical Journals developed by the International Committee of Medical Journal Editors.

Editorial team selects manuscripts to be published in according with the Journal’s publication ethics statement (see in details here). The journal publishes the results of research conducted in compliance with the principles of biomedical ethics and that meet Good Clinical Practice (GCP) standards. The journal only accepts original manuscripts that have not previously been published (including publications in any other language) or submitted for publication in any other journal.

In case of ethics violation detection a manuscript will be rejected despite of publication stage.

The title page should include:

• article’s title;
• authors’ names (first and middle name initials, full surname);
• place of work of each author (official name of the institution);
• the author responsible for correspondence with the editorial team should be tagged with an asterisk (*), and provide their e-mail and telephone contact details (for the use of the editorial team; these will not be published).

The final page should include information about the authors in the order of their presentation in the article:

• full name (first, middle name (if applicable), surname);
• position held; official name of institution, and name of department/division;
• degree(s);
• authors’ academic indices:
• ORCID (obligatory for all authors);
• ResearcherID, ScopusID (if applicable);
• e-mail addresses. The author responsible for correspondence with the editorial team should be tagged with an asterisk (*).

Manuscripts are accepted in DOC, DOCX, and RTF format. Text should be in the Times New Roman font, in 14-point font, with a one-and-a-half line spacing. All pages should be numbered.

Italic and bold typefaces are allowed for emphasis within the text; underlining is only applicable for Internet links.

Manuscript length (excl. abstract, illustrative materials, and bibliography):

• research results should not exceed 40,000 characters, including spaces;
• reviews should not exceed 60,000 characters, including spaces;
• case reports should not exceed 20,000 characters, including spaces;
• information, commentary, and letters to the editor should not exceed 10,000 characters, including spaces.

Longer manuscripts are only accepted with the specific agreement of the editors.

Recommended guidelines for manuscript structure

The editorial board of Consortium PSYCHIATRICUM strongly recommends that authors use the EQUATOR Network publication guidelines when preparing manuscripts. A unified standard for reporting research ensures the accuracy, completeness, and transparency of articles. As a result, the scientific reliability and value of published materials are significantly enhanced.

1. Manuscripts describing original research (including study protocols and systematic reviews) must be submitted to the editorial office in strict accordance with the structure of the checklist from one of the reporting guidelines available in the EQUATOR Network For most studies, one of the following guidelines will be appropriate:

• Observational studies (STROBE)
• Randomized trials (CONSORT)
• Study protocols (SPIRIT)
• Narrative literature reviews (check list)
• Genetic associations (STREGA)
• Survey studies (CROSS)
• Qualitative researches (SRQR)
• Systematic reviews (PRISMA)
• Scoping reviews (PRISMA-ScR)
• Diagnostic/prognostic studies (STARD)
• Prediction models (TRIPOD-AI)
• Case reports (CARE)
• Test adaptation (TARES)
  
  2. The list of guidelines provided is not exhaustive. If none of the indicated guidelines is suitable for your research, please select an appropriate one by searching the EQUATOR Network library (search options are available by study type, clinical area, manuscript section, and keywords).
  3.  If you experience difficulties in choosing the appropriate guideline, please contact the editorial office at the editor@consortium-psy.com.
  4. If your study is reported using an unsuitable guideline, you will be asked to resubmit your manuscript in accordance with the checklist of the guideline relevant to your work.
  5. If your manuscript is prepared using checklists from two or more guidelines, please indicate the source for each section of your manuscript.
  6. If any checklist item in the chosen guideline does not apply to your study, please indicate “not applicable” or similar (the item heading must be retained). Such items will be removed from the manuscript if your work is accepted for publication.
  
  

  For details on how to select and work with checklists, please see here.

Abstracts should contain from 150 to 250 words. Abstracts should not contain acronyms, references, or illustrative materials. 

Abstracts of the original article should be structured so as to contain:

• INTRODUCTION;
• AIM;
• METHODS;
• RESULTS;
• CONCLUSIONS.

Abstracts of narrative reviews and case reports can be prepared without structuring.

Four to five keywords should be provided.

The original article should contain the following sections:

Introduction

The introduction should include:

• a brief review of the literature with emphasis on recent research;
• research justification;
• research objective;
• research hypothesis.

Material and methods

These should ensure the possibility of the research being reproduced by other research groups by providing sufficient details to allow reproduction using the described study methods, and should include:  

• design of the study;
• methods:
  
  • inclusion and exclusion criteria;
  • key and additional research outcomes;
  • methods of the outcome estimation with an indication of the diagnostic tools and equipment used;
  • principles of study group formation.
• characteristics of patients or other objects/subjects of research;
• methods of statistical analysis.

The process by which study groups were formed can be presented graphically (“patient flow chart”). When referring to any equipment used in the study, you should indicate in brackets the manufacturer and country of origin; when listing drugs and chemicals, you should specify their international non-proprietary name, dosage, and route of administration.

If your study has been performed on humans or animals, please specify the ethics committee that has approved your research (please provide its conclusions, indicating document number, date of signing, and the official name of the ethics committee), as well as information about the informed, signed consent of the participants or evidence of compliance with the principles of bioethics.   

Results

The research results should correspond with the research purpose and should offer data to confirm or reject the research hypothesis. Illustrative materials (graphs, tables, or figures) should be used with the relevant references in the text. Please avoid any repetition of information from illustrative materials in the text. It is recommended that you include no more than five illustrative elements. If necessary, tables with data or measuring scales, etc., may be presented as supplementary material to the main manuscript.     

Discussion

The discussion should contain new and important aspects of the study results, an analysis of any possible mechanisms, and an interpretation of the results, as well as comparisons with other studies. Recommendations for clinical practice and the application of results in practice or in future studies are welcomed. The section should describe the strengths and weaknesses of the study, and make appropriate comparison with existing analogues. You should avoid any repetition of information from the ‘Introduction’ section and too detailed a presentation of the data from the ‘Results’ section.

Possible structure of the ‘Discussion’:

• main result – summary of the answer to the research question (one paragraph);
• strengths and limitations of the study;
• comparison of the results obtained with data from other studies, with an analytical assessment of your own results by comparison with other studies;
• application of the results – with regard to research activities, practical work, healthcare organizations.

Conclusion

The conclusion should be brief (a few sentences only) and should summarize the work carried out, the novelty of the data obtained, and the prospects for its future use. 

A review may be systematic, or systematic with a meta-analysis or narrative. The type of review should be indicated in the title of the manuscript.

• Systematic review and meta-analysis

Prior to submitting the manuscript, you should register the systematic review with PROSPERO (https://www.crd.york.ac.uk/prospero/). When registered, the registration number of the review in PROSPERO should be indicated in the manuscript.   

When preparing a manuscript with a systematic review and meta-analysis, you should follow the PRISMA (http://prisma-statement.org/PRISMAStatement/Checklist.aspx) or AMSTAR (https://amstar.ca/Amstar_Checklist.php) systematic review plan. 

• Narrative review

The narrative review should contain an introduction that indicates the review justification and purpose. The main text of the review should be structured, and information should be presented in the titled sections. The review should include a discussion of the obtained results. The conclusion (obligatory section) should summarize the results, comply with the review’s purpose, and specify potential areas for the use of the data obtained in research and medical practice.

The full text of a clinical case report should include:

• introduction (including a brief literature review);
• the clinical case;
• discussion of the results (with a comparison with previous results from the literature);
• conclusions.

• Acknowledgements (this section is optional).
• Authors’ contributions.
• Conflicts of interest.
• Sources of funding.

Authors’ contributions

Only those persons who have made a significant contribution to the conception of the work, the development, execution, and/or interpretation of the results of the presented study, as well as to the process of writing the manuscript (including scientific and stylistic editing and design in accordance with the requirements of the journal) may be the Authors of the publication. When submitting a manuscript to the journal, Authors shall ensure that:

• all participants who made a significant contribution to the reported study are presented as Co-Authors;
• those who did not participate in the study are not listed as Co-Authors;
• all Co-Authors have seen and approved the final version of the paper and agreed to its submission for publication—this shall be confirmed by the signatures of all Authors in the cover letter.

Authors should indicate their role in accordance with Contributor Roles Taxonomy (CRediT)^[1]

Editors request that authors comply with the NLM (National Library of Medicine) citation style when formatting references.

In order for the data relating to authors’ publications to be correctly presented in the international abstract and citation databases of research (SCOPUS, Web of Science, Google Scholar, etc.), you should follow certain rules when formatting references in a paper and in the list of references.   

Editors would prefer authors to provide lists of references in English, considering the translation or transliteration of non-English sources in compliance with the presented recommendations.

The website https://www.citethisforme.com can be used to automatically generate a correct bibliographic description of an article in English in the NLM citation style.  

In-text citations

• Each reference should be identified sequentially in the text, figures, or tables in square brackets and using arabic numerals. It is only possible to cite the reference in the figure or the table if it is in sequence with the references cited in the text;
• For multiple citations, place a comma (no space in front) between the numbers; join a closed series with a hyphen;
• Only the authors’ surnames should be quoted in the text. If there are two authors, provide both surnames; if there are more than two authors, quote the first surname followed by “et al.”.

General requirements for sources. It is recommended that you include bibliographic descriptions of scientific sources from the last decade in the list of cited sources (this does not refer to publications on the history of psychiatry). References to your own publications should not exceed 10% of the total number of citations.  

Types of sources. It is acceptable to cite any source; however, references to unpublished work, state documents (government regulations, laws, etc.), or newspaper articles should appear as footnotes or in the text rather than in the list of references.  

Order of presenting sources. The list of references should appear on a new page at the end of your paper. The page should feature the header ‘References’. References are to be listed numerically in order of citation, NOT in alphabetical order.

Presentation and number of authors. Authors’ names and initials should be specified in the list of references without a dot. If there are up to six authors, all authors should be listed. If there are more than six authors, only the first three authors should be listed, followed by “et al.” A comma should be inserted between the name of the last author and “et al.”

Titles and abbreviations. It is unacceptable to abbreviate (or change) the titles of articles or the names of journals. With reference to English language journals, official journal title abbreviations are acceptable. To find an authoritative list of journal title abbreviations, use the CAS Source Index, WorldCat library, or the Web of Science (ISI) catalogue, or MedLine catalogue (NLM Catalogue). If no official abbreviation for the journal title can be found, the name of the journal should be specified in full.

DOI. In all cases, when the source cited has a Digital Object Identifier (DOI), this should be specified at the end of the reference. To verify whether the DOI is valid, visit http://search.crossref.org/ or https://www.citethisforme.com, and enter the title of the source in English in the search box. The latter site, in addition to the DOI, automatically generates a correct bibliographic description of the article in English in the NLM citation style. The vast majority of journal articles since 2000 have been registered with CrossRef and thus have a unique DOI. 

Punctuation:

• when indicating the author’s name, the initials should be placed after the surname;
• initials should not have spaces or points between them;
• authors’ names should be separated by commas;
• a full stop should be inserted after the name of publication;
• when indicating the date of the publication, publisher, or other data, the punctuation should comply with the examples listed below.

Language

References should be presented in Latin script. References to sources in non-Latin script should be presented as per the OFFICIAL TRANSLATION or TRANSLITERATION (depending upon the specific element of the description). 

Translation and transliteration

Non-English information on sources in the list of references should either be transliterated (using the Latin script alphabet) or translated.

• If an article is presented in Latin script, it should be cited in the original language;
• If an article is presented in non-Latin script, an OFFICIAL TRANSLATION or Latin script transliteration should be provided. For books, a Latin script transliteration should be provided. The original language of the article should be indicated after the title, prior to the journal name;
• References may include both transliterated (e.g., authors’ names, names of journals) and translated (e.g., publication title) elements.

Transliteration standard. Use the BSI (British Standard Institute, UK) standard for transliteration: https://antropophob.ru/translit-bsi.

• Names of authors, editors. Surnames and initials of all authors should be indicated in the reference as they appear in the original publication. If the authors’ names are presented in the original publications in Latin script, this variant should be used in the reference (regardless of the transliteration system used in the original source). If the authors’ names are not given in Latin in the official sources (journal websites, databases), they should be transliterated in accordance with the BSI standard.
• Article title. If the article cited has an official translation or a translated title in English (this should be checked on journal websites or in databases), this variant should be given. If no title is presented in Latin script in the official publication, a title transliterated in accordance with the BSI standard should be provided.
• Journal title. Certain non-English, scientific journals have official titles in English in addition to titles in native languages (e.g., the Russian Journal of Psychiatry, in addition to the Russian language title, has both the official name in English, ‘Russian Journal of Psychiatry’ and the transliterated title ‘Rossiiskii psikhiatricheskii zhurnal’). Thus, either the translated or transliterated title of the journal should be provided in the reference. The translated title of the journal may be taken from the official journal’s website (or where it is possible to use data governing the accurate quotation of English language titles from the article cited) or checked in databases. You should not translate journal titles yourself.
• Place of publication. According to the NLM Citation Guide (last edition), you need not indicate the place of publication.
• Name of publisher. The name of the publisher should only be transliterated (except in rare cases where publishers have official English language titles).

Examples of citing in ‘References’

All examples can be found under the link: https://www.ncbi.nlm.nih.gov/books/NBK7256/. Should you require any additional information or assistance, the CP editorial team is at your disposal (editor@consortium-psy.com)

Units should be provided in the International System of Units (SI). If the study was carried out using devices that provide measurements in other units, these need to be converted to the SI system with an indication of the conversion factor or software version in ‘Materials and methods’.

Abbreviations/acronyms should not be used except for those that are generally accepted. The meanings of abbreviations/acronyms in the text of the article must be given in full at their first mention (e.g., neuromuscular disease (NMD)).

Gene names should be specified in italics; protein names should be specified in regular font.

Illustrative materials can include photographs, figures, images, diagrams, graphs, charts, and tables. Illustrative materials should be submitted in the form of high-quality images to enable good picture reproduction quality in both the electronic and printed versions of the journal. Should the illustrative materials have previously been published, the author is obliged to provide permission for their use otherwise their use will be considered plagiarism and the study will not be accepted for publication.

Illustrative material should be submitted as separate files and should be accompanied by links in the relevant sections within the body of the article text. References should appear in parentheses, e.g., (fig. 1), (table 1).

Figures, graphs, diagrams, and charts should be provided in editable formats. Illustrative materials should meet further technical requirements:  

• tables should be presented in their original Word or Excel versions. If other programs were used (e.g., EndNote), the associated files should be provided in PDF format, with a copy function available;
• images, illustrations, graphs, and diagrams should be presented in TIFF or EPS format; JPG files should have a resolution of at least 300 dpi (dots per inch);
• photographs are accepted in TIFF or JPG format, with a resolution of at least 300 dpi. If a photograph is small (for example, 3 × 4 cm), you should choose a resolution of 1200 dpi when scanning. The eyes of patients or healthy subjects in photographs should be masked; if not, the author should submit patients’ written permission for their full likenesses to be presented.

If you cannot provide files in these formats, please contact the editorial staff for assistance.

All figures must be numbered and provided with captions. Fragments/elements of figures should be presented as lower-case letters – “a”, “b”, etc. All abbreviations, symbols in the form of curves, letters, numbers, etc., used in the figure should be explained in an associated caption.

Tables should be ostensive and should display a title and serial number. Graph headers should correspond to their content. The data in the tables should not repeat any data in the figures or text, or vice versa. All abbreviations/acronyms should be explained in a footnote to the associated table. You need to specify the statistical method used for analysis and for the corresponding confidence value (p). All information contained in the table, including its title and notes (if applicable), should be presented in the language of the article. If the table size exceeds one typewritten page, the table should be provided as a separate file in a DOC, DOCX, or RTF format.

The integration of Artificial Intelligence (AI) into scientific workflows is accelerating, offering researchers novel tools for data analysis, text refinement, and insight generation. Responsible and transparent use of AI is essential for all authors, from beginners to experienced users.

1. Author Responsibility and Oversight

AI must serve strictly as an auxiliary tool in manuscript preparation, not as a substitute for substantive intellectual contribution. Authors bear full and final responsibility for the accuracy, integrity, and validity of all manuscript content. This includes verifying every claim, citation, reference, and analytical procedure. All conclusions and core arguments must originate from the authors' own critical thinking and expert judgment. Any content created or significantly refined with AI assistance must undergo meticulous review and validation by the authors prior to submission. The final manuscript must unequivocally reflect the authors' unique scholarly contribution, adhere to their stylistic voice, and comply with the journal's ethical and editorial standards.

2. Disclosure of AI Use

Authors are required to declare any use of AI tools during manuscript preparation in a transparent and structured manner.

• AI in the Research Process: If AI was used directly in the research methodology (e.g., for data processing, literature synthesis, code generation, image analysis), this must be described in detail within the Methods section. The description should enable independent reproducibility and include:
  
  • Name of the AI tool/software/platform.
  • Version number and developer/provider.
  • Access point (URL, if applicable).
  • A clear description of the application workflow.
  • Identification of the researcher(s) who operated the tool.
  • The specific prompts/queries used (sequence and details).
  • Dates of use (where relevant).
  • A statement on how the authors verified the accuracy and reliability of the AI-generated outputs.

Examples:

"An initial screening of over 500 article abstracts was performed using GPT-4 (accessed January 2025) to categorize them according to the pre-defined criteria. All AI-assisted categorizations were subsequently verified and validated by the authors, who made the final inclusion/exclusion decisions."
"Regression analysis scripts were initially generated using Claude 3.5 Sonnet (accessed August 2025). All AI-generated code was reviewed, tested, and refined by the authors, who confirm the accuracy and reproducibility of the final analytical outputs."
"Thematic analysis of qualitative interview data was assisted by LLAMA 3 (accessed May 2025). All AI-suggested themes were reviewed and validated by the authors to ensure interpretive accuracy. Prompts and model parameters are provided in Appendix S2. All data were anonymized prior to AI-assisted analysis in compliance with institutional confidentiality protocols."

• AI in Figure/Illustration Creation: Disclosure is mandatory if AI tools were used to create or substantively edit any visual material (graphs, diagrams, schematics, or data-derived artwork) included in the manuscript. The figure caption must specify:
  
  • Name and version of the AI tool.
  • Year of use.
  • The specific role of the AI (e.g., "for initial concept generation," "for layout assembly").
  • The author's role in guiding the process and validating/editing the final output.

Important Restrictions: The use of AI to create, modify, or enhance factual, evidentiary images (e.g., micrographs, medical scans, original experimental data visualizations) that form the basis of scientific claims is strictly prohibited, as it compromises their veracity and auditability. AI may be used for image analysis as part of a defined methodology, which must be fully detailed in the Methods section.

Example:

"Figure 1. Conceptual pathway of therapeutic intervention. The initial schematic concept was generated using Midjourney (v6.0, March 2024) and subsequently extensively modified and validated for clinical accuracy by the authors using Adobe Illustrator."

• AI in Manuscript Drafting: Disclosure is required if AI was used to generate draft text for any part of the manuscript or supplementary materials. This must be declared in a dedicated section titled "Generative AI Use Statement” before the References, including:
  
  • The purpose of using the AI.
  • The specific sections of the manuscript AI was applied to.
  • Name of the tool (with URL), version, and developer.
  • Date(s) of use.

Example:

“The authors used GPT-4 (August 2025) to draft an initial version of the Acknowledgments section and to assist in translating the Methods section from Spanish. The clarity and flow of the Discussion section were improved using Gemini (July 2025). All AI-processed text was thoroughly reviewed, edited, and fact-checked by the authors, who take full responsibility for its final content and accuracy.”

• AI in Basic Editing Tasks:Consortium Psychiatricum does not require disclosure for AI use limited to:
  
  • Grammar, spelling, and general style checking.
  • Reference list formatting.
  • Translation, provided the output is subsequently verified by a professional translator or native speaker.

Upon detection of AI-generated content coupled with author claims of its auxiliary use, the editorial board reserves the right to request the original pre-AI manuscript drafts, which the authors are obligated to provide.

3. Legal Compliance and Data Security

• Before using any AI tool, authors must review its Terms of Service and Privacy Policy. Ensure that the agreement does not transfer exclusive rights to the AI developer for user-generated content and does not restrict its subsequent use by the authors, journal, or publisher.
• Authors must not uploadconfidential, personally identifiable, or unpublished proprietary data to AI platforms without first confirming the service provides adequate, legally compliant data protection safeguards.

4. Ethical Considerations and Authorship

• Authors must actively consider and address potential biases inherent in AI outputs and describe steps taken to identify and mitigate them.
• AI tools cannot be listed as authors or co-authorson a manuscript.
• AI may not be cited as an original sourceof information. Content generated by AI (text, images) lacks independent intellectual agency and therefore cannot be referenced. All supporting claims must be sourced to citable, human-generated literature or primary data.